Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,040 recruiting studies

Lymphoproliferative Disorders trial results

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Nagoya, Aichi-ken, Japan
  • Japanese Foundation for Cancer Research Koto, Tokyo, Japan
  • The Cancer Institute Hospital of JFCR Koto, Tokyo, Japan
  • Yamagata University Hospital Yamagata, Japan
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles (UCLA) Health Los Angeles, California, United States
  • Emory University Clinic/Winship Cancer Institute Atlanta, Georgia, United States
View all 69 locations
Conditions
Depressive Disorder, Depressive Disorder, Major, Depressive Episode, +13 more
Locations
  • Inje University Ilsan Palk Hospital Ilsan, South Korea
  • Jeju National University Hospital Jeju City, South Korea
  • Seoul ST. Mary's Hospital Seoul, South Korea
  • Yeouido ST. Mary's Hospital Seoul, South Korea
Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Site US0006 Duarte, California, United States
  • Site US0002 Stanford, California, United States
  • Site US0004 Fairway, Kansas, United States
  • Site US0001 New York, United States
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Rrmc Los Angeles, California, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States